Puma Biotechnology Inc (PBYI) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Puma Biotechnology Inc   (NASDAQ: PBYI)
 

Puma Biotechnology Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Puma Biotechnology Inc 's inventory turnover ratio sequentially decreased to 6.29 in the second quarter 2026, unsurprisingly, as the Puma Biotechnology Inc markets continue to deteriorate, and PBYI's faces growing challenges to bring down its inventories. Puma Biotechnology Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 58 days, from 51 days, in the Mar 31 2026 quarter.

Within Healthcare sector 62 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 358 in the first quarter 2026, to 547.

PBYI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Puma Biotechnology Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PBYI Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 55.09 % -0.66 % -36.78 % 254.51 % -5.06 %
Y / Y Cost of Sales Growth 1.41 % -1.25 % 66.13 % -58.16 % 15.42 %
Inventory Turnover Ratio (TTM) 6.29 7.19 7.19 5.51 9.17
PBYI's Total Ranking # 547 # 358 # 319 # 398 # 327
Average inventory processing period 58 51 51 66 40
Seq. Inventory Growth 53.27 % 57.62 % -41.8 % 10.3 % -1.83 %
Seq. Cost of Sales Growth 19.68 % -54.93 % 89.99 % -1.04 % 16.53 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 13
Healthcare Sector # 63
Overall Market # 547

Inventory Turnover Ratio Statistics
High Average Low
13.89 10.08 5.51
(Mar 31 2021)   (Sep 30 2025)



PBYI Company Profile >> Back to PBYI Efficiency Comparisons >> Compare PBYI Inventory Turnover Ratio to its Competitors

Financial Statements
Puma Biotechnology Inc 's Inventories $ 13 Millions Visit PBYI's Balance sheet
Puma Biotechnology Inc 's Cost of Revenues TTM $ 58 Millions Visit PBYI's Income Statement
What are PBYI's Sales? Visit PBYI's Sales by Segment

Other Inventory Turnover Ratios
Puma Biotechnology Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PBYI's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PBYI's Competitors
Inventory Turnover Ratio for PBYI's Suppliers
Inventory Turnover Ratio for PBYI's Customers

You may also want to know
PBYI's Sales Growth Rates PBYI's Pe Price to earnings ratio PBYI's Receivables Turnover Ratio PBYI's Stock Quote
PBYI's Net Income Growth Rates PBYI's Ps Price to Sales ratio PBYI's Sales per Employee PBYI's Asset Turnover Ratio
PBYI's Net Margin PBYI's Pb Price to Book ratio PBYI's Financial Strength Ratios PBYI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Precision Optics Corporation Inc   6.97 $ 26.101  Millions$ 4  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.